NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Box Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Published 24/05/2024, 15:44
© Reuters.  Box Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
BOX
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Box, Inc. (NYSE:BOX) is set to release first-quarter financial results, after the closing bell on Tuesday.

Analysts expect the Redwood City, California-based company to report quarterly earnings at 36 cents per share, up from 32 cents per share in the year-ago period. Box is expected to post revenue of $262.04 million, according to data from Benzinga Pro.

On May 16, Box announced the appointment of Steve Murphy, CEO of Epicor Software, to its Board of Directors.

Box shares fell 0.7% to close at $25.88 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Morgan Stanley analyst Josh Baer downgraded the stock from Overweight to Equal-Weight and cut the price target from $35 to $32 on May 22. This analyst has an accuracy rate of 60%.
  • JMP Securities analyst Erik Suppiger reiterated a Market Outperform rating with a price target of $32 on March 20. This analyst has an accuracy rate of 75%.
  • Citigroup analyst Steven Enders maintained a Buy rating and raised the price target from $29 to $32 on March 6. This analyst has an accuracy rate of 61%.
  • JP Morgan analyst Pinjalim Bora maintained an Overweight rating and increased the price target from $31 to $32 on March 6. This analyst has an accuracy rate of 63%.
  • Raymond James analyst Brian Peterson maintained an Outperform rating and cut the price target from $33 to $30 on Dec. 6, 2023. This analyst has an accuracy rate of 70%.
Read This Next: $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.